FLIP overexpression inhibits death receptor-induced apoptosis in malignant mesothelial cells

Oncogene

Volumn 23, Issue 47, 2004, Pages 7753-7760

  Rippo, Maria Rita ^a   Moretti, Simona ^a   Vescovi, Silvia ^a   Tomasetti, Marco ^a   Orecchia, Sara ^c   Amici, Giuseppe ^d   Catalano, Alfonso ^a,b   Procopio, Antonio ^a,b  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b INRCA   (Italy)

^c C Arrigo Children's Hospital   (Italy)

^d G Salesi Children's/Mother's Hosp   (Italy)

Author keywords

Apoptosis; Caspase 8; Fas; FLIP; Malignant mesothelioma; TRAIL

Indexed keywords

BENZYLOXYCARBONYLISOLEUCYLGLUTAMYLTHREONYLASPARTYL FLUOROMETHYL KETONE; CASPASE 8; DEATH RECEPTOR 5; FAS ANTIGEN; FLICE INHIBITORY PROTEIN; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; CELL DEATH; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MALIGNANT MESOTHELIOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANTIGENS, CD95; APOPTOSIS; BASE SEQUENCE; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CASPASE 8; CASPASES; CELL LINE; CELL LINE, TUMOR; CYSTEINE PROTEINASE INHIBITORS; DNA PRIMERS; EPITHELIUM; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MESOTHELIOMA; OLIGOPEPTIDES; PLOIDIES; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; RECEPTORS, TUMOR NECROSIS FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 7644244878     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208051     Document Type: Article

References (38)

1. Attanoos R and Gibbs A. (1997). Histopathology, 30, 403-418.
2. Bernard D, Quatannens B, Vanderbunder B and Abbadie C. (2001). J. Biol Chem., 276, 27322-27328.
3. Bradley M, Zeytun A, Rafi-Janaireh A, Nagarkatti P and Nagarkatti M. (1998). Blood, 11, 4248-4255.
4. Carbone M, Pass HI, Rizzo P, Marinetti M, Muzio MD, Mew DJY, Levine A and Procopio A. (1994). Oncogene, 9, 1781-1790.
5. Catalan MP, Subira D, Reyero A, Selgas R, Ortiz-Gonzalez A, Egido J and Ortiz A. (2003). Kidney Int., 64, 321-330.
6. Djerbi M, Screpanti V, Catrina I, Bogen B, Biberfeld P and Grandien A. (1999). J. Exp. Med., 190, 1025-1032.
7. French L and Tschopp J. (1999). Nat. Med., 5, 146-147.
8. French LE and Tschopp J. (2002). Semin. Cancer Biol., 12, 51-55.
9. Frost P, Ng CP, Belldegrun A and Bonavida B. (1997). Cell. Immunol., 180, 70-83.
10. Hahne M, Rimoldi D, Schroter M, Romero P, Schreier M, French LE, Schneider S, Bornard T, Fontana A, Lienard D, Cerottini J-C and Tschopp J. (1996). Science, 274, 1363-1366.
11. Jaklitsch MT, Grondin SC and Sugarbaker DJ. (2001). World J. Surgery, 25, 210-217.
12. Krueger A, Baumann S, Krammer PH and Kirchoff S. (2001). Mol. Cell. Biol., 21, 8247-8254.
13. Kumar-Singh S, Weyler J, Martin M, Vermeulen P and Van Marck E. (1999). J. Pathol., 189, 72-78.
14. Lew F, Tsang P, Holland J, N W, IJ S and JG B. (1986). J. Clin. Immunol., 6, 225-233.
15. Liu W, Bodle E, Chen JY, Gao M, Rosen GD and Broaddus VC. (2001). Am. J. Respir. Cell Mol. Biol., 25, 111-118.
16. Manning L, Davis M and Robinson B. (1991). Clin. Exp. Immunol., 83, 85-91.
17. Medema JP, Tong TJD, Hall Cjv and Melief Offringa R. (1999). J. Exp. Med., 190, 1033-1038.
18. Mitsiades N, Mitsiades CS, Poulaki V, Anderson KC and Treon SP. (2002). Blood, 99, 2162-2171.
19. Mutsaers SE. (2002). Respirology, 7, 171-191.
20. Nagaraju K, Casciola-Rosen L, Rosen A, Thompson C, Loeffler L, Parker T, Danning C, Rochon P, Gillespie J and Plotz P. (2000). J. Immunol., 164, 5459-5465.
21. Narasimhan SR, Yang L, Gerwin BI and Broaddus VC. (1998). Am. J. Physiol., 275 (Lung Cell. Mol. Physiol.), L165-L171.
22. O'Connel J, O'Sullivan GC, Collins JK and Shanahan F. (1996). J. Exp. Med., 184, 1075-1082.
23. Peter ME and Krammer PH. (2003). Cell Death Differ., 10, 26-35.
24. Plasilova M, Zivny J, Jelinek J, Neuwirtova R, Cermak J, Necas E, Andera L and T S. (2002). Leukemia, 16, 67-73.
25. Romano M, Catalane A, Nutini M, D'urbano E, Crescenzi C, Claria J, Libner R, Davi G and Procopio A. (2001). FASEB J., 15,2326-2336.
26. Roth W, Isenmann S, Nakamura M, Platten M, Wick W, Kleihues P, Bahr M, Ohgaki H, Ashkenazi A and Weller M. (2001). Cancer Res., 61, 2759-2765.
27. Screpanti V, Wallin R, Ljunggren H-G and Grandien A. (2001). J. Immunol., 167, 2068-2073.
28. Siegmund D, Hadwiger P, Pfizenmaier K and Vornlocher H-P. (2002). Mol. Med., 8, 725-732.
29. Stewart JH, Nguyen DM, Chen GA and Schrump DS. (2002). J. Thoracic Cardiovasc. Surg., 123, 295-302.
30. Strizzi L, Catalano A, Vianale G, Orecchia S, Casalini A, Tassi G, Puntoni R, Mutti L and Procopio A. (2001). J. Pathol., 193, 468-475.
31. Tepper CG and Seldin MF. (1999). Blood, 94, 1727-1737.
32. Thomas RK, Kallenborn A, Wickenhauser C, Schultze JL, Draube A, Vockerodt M, Re D, Diehl V and Wolf J. (2002). Am. J. Pathol., 160, 1521-1528.
33. Tomasetti M, Rippo MR, Moretti S, Alleva R, Andera L, Neuzil J and Procopio A. (2004). Br. J. Cancer, 90, 1644-1653.
34. Tomek S, Emrl S, Krejcy K and Manegold C. (2003). Br. J. Cancer, 88, 167-174.
35. Vivo C, Liu W and Broaddus VC. (2003). J. Biol. Chem., 278, 25461-25467.
36. Wall NR and Shi Y. (2003). The Lancet, 362, 1401-1403.
37. Wright SC, Zhong J and Larrick JW. (1994). FASEB J., 8, 654-660.
38. Zang D, Goodwin R, Loken M, Bryant E and Deeg J. (2001). Blood, 98, 3058-3065.